Advertisement
U.S. markets open in 51 minutes

PuraPharm Corporation Limited (1498.HK)

HKSE - HKSE Delayed Price. Currency in HKD
0.830+0.020 (+2.47%)
At close: 03:03PM HKT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in HKD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Upgrade to begin using 40 years of financial statements and get so much more.
 
As of Date: 3/28/2024
Current
Market Cap (intraday)
320.68M
Enterprise Value
727.45M
Trailing P/E
N/A
Forward P/E
11.49
PEG Ratio (5 yr expected)
N/A
Price/Sales (ttm)
0.78
Price/Book (mrq)
1.48
Enterprise Value/Revenue
1.76
Enterprise Value/EBITDA
-13.05

Trading Information

Stock Price History

Beta (5Y Monthly) 0.23
52-Week Change 3-25.00%
S&P500 52-Week Change 329.57%
52 Week High 31.260
52 Week Low 30.740
50-Day Moving Average 30.818
200-Day Moving Average 30.944

Share Statistics

Avg Vol (3 month) 332.48k
Avg Vol (10 day) 322.25k
Shares Outstanding 5395.9M
Implied Shares Outstanding 6395.9M
Float 8262.81M
% Held by Insiders 152.94%
% Held by Institutions 10.00%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4May 31, 2017
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2022
Most Recent Quarter (mrq)Jun 30, 2023

Profitability

Profit Margin -28.61%
Operating Margin (ttm)-11.55%

Management Effectiveness

Return on Assets (ttm)-4.75%
Return on Equity (ttm)-41.37%

Income Statement

Revenue (ttm)412.39M
Revenue Per Share (ttm)1.04
Quarterly Revenue Growth (yoy)-15.50%
Gross Profit (ttm)N/A
EBITDA -57.15M
Net Income Avi to Common (ttm)-117.99M
Diluted EPS (ttm)-0.300
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)76.63M
Total Cash Per Share (mrq)0.19
Total Debt (mrq)454.85M
Total Debt/Equity (mrq)210.25%
Current Ratio (mrq)0.68
Book Value Per Share (mrq)0.55

Cash Flow Statement

Operating Cash Flow (ttm)38.26M
Levered Free Cash Flow (ttm)43.54M